Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Prophylactic Human Vaccines Market Size Growth Rate by Type (2014-2025) 1.4.2 Type I 1.4.3 Type II 1.5 Market by Application 1.5.1 Global Prophylactic Human Vaccines Market Share by Application (2014-2025) 1.5.2 Pediatric Prophylactic Vaccines 1.5.3 Adult Prophylactic Vaccines 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Prophylactic Human Vaccines Market Size 2.2 Prophylactic Human Vaccines Growth Trends by Regions 2.2.1 Prophylactic Human Vaccines Market Size by Regions (2014-2025) 2.2.2 Prophylactic Human Vaccines Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Prophylactic Human Vaccines Market Size by Manufacturers 3.1.1 Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019) 3.1.2 Global Prophylactic Human Vaccines Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Prophylactic Human Vaccines Market Concentration Ratio (CR5 and HHI) 3.2 Prophylactic Human Vaccines Key Players Head office and Area Served 3.3 Key Players Prophylactic Human Vaccines Product/Solution/Service 3.4 Date of Enter into Prophylactic Human Vaccines Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Prophylactic Human Vaccines Market Size by Type (2014-2019) 4.2 Global Prophylactic Human Vaccines Market Size by Application (2014-2019) 5 United States 5.1 United States Prophylactic Human Vaccines Market Size (2014-2019) 5.2 Prophylactic Human Vaccines Key Players in United States 5.3 United States Prophylactic Human Vaccines Market Size by Type 5.4 United States Prophylactic Human Vaccines Market Size by Application 6 Europe 6.1 Europe Prophylactic Human Vaccines Market Size (2014-2019) 6.2 Prophylactic Human Vaccines Key Players in Europe 6.3 Europe Prophylactic Human Vaccines Market Size by Type 6.4 Europe Prophylactic Human Vaccines Market Size by Application 7 China 7.1 China Prophylactic Human Vaccines Market Size (2014-2019) 7.2 Prophylactic Human Vaccines Key Players in China 7.3 China Prophylactic Human Vaccines Market Size by Type 7.4 China Prophylactic Human Vaccines Market Size by Application 8 Japan 8.1 Japan Prophylactic Human Vaccines Market Size (2014-2019) 8.2 Prophylactic Human Vaccines Key Players in Japan 8.3 Japan Prophylactic Human Vaccines Market Size by Type 8.4 Japan Prophylactic Human Vaccines Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Prophylactic Human Vaccines Market Size (2014-2019) 9.2 Prophylactic Human Vaccines Key Players in Southeast Asia 9.3 Southeast Asia Prophylactic Human Vaccines Market Size by Type 9.4 Southeast Asia Prophylactic Human Vaccines Market Size by Application 10 India 10.1 India Prophylactic Human Vaccines Market Size (2014-2019) 10.2 Prophylactic Human Vaccines Key Players in India 10.3 India Prophylactic Human Vaccines Market Size by Type 10.4 India Prophylactic Human Vaccines Market Size by Application 11 Central & South America 11.1 Central & South America Prophylactic Human Vaccines Market Size (2014-2019) 11.2 Prophylactic Human Vaccines Key Players in Central & South America 11.3 Central & South America Prophylactic Human Vaccines Market Size by Type 11.4 Central & South America Prophylactic Human Vaccines Market Size by Application 12 International Players Profiles 12.1 ALK 12.1.1 ALK Company Details 12.1.2 Company Description and Business Overview 12.1.3 Prophylactic Human Vaccines Introduction 12.1.4 ALK Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.1.5 ALK Recent Development 12.2 Altimmune 12.2.1 Altimmune Company Details 12.2.2 Company Description and Business Overview 12.2.3 Prophylactic Human Vaccines Introduction 12.2.4 Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.2.5 Altimmune Recent Development 12.3 Bavarian Nordic 12.3.1 Bavarian Nordic Company Details 12.3.2 Company Description and Business Overview 12.3.3 Prophylactic Human Vaccines Introduction 12.3.4 Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.3.5 Bavarian Nordic Recent Development 12.4 BiondVax Pharmaceuticals 12.4.1 BiondVax Pharmaceuticals Company Details 12.4.2 Company Description and Business Overview 12.4.3 Prophylactic Human Vaccines Introduction 12.4.4 BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.4.5 BiondVax Pharmaceuticals Recent Development 12.5 Bharat Biotech International 12.5.1 Bharat Biotech International Company Details 12.5.2 Company Description and Business Overview 12.5.3 Prophylactic Human Vaccines Introduction 12.5.4 Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.5.5 Bharat Biotech International Recent Development 12.6 GlaxoSmithKline 12.6.1 GlaxoSmithKline Company Details 12.6.2 Company Description and Business Overview 12.6.3 Prophylactic Human Vaccines Introduction 12.6.4 GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.6.5 GlaxoSmithKline Recent Development 12.7 Hualan Biological Engineering 12.7.1 Hualan Biological Engineering Company Details 12.7.2 Company Description and Business Overview 12.7.3 Prophylactic Human Vaccines Introduction 12.7.4 Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.7.5 Hualan Biological Engineering Recent Development 12.8 Janssen Pharmaceuticals 12.8.1 Janssen Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Prophylactic Human Vaccines Introduction 12.8.4 Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.8.5 Janssen Pharmaceuticals Recent Development 12.9 MedImmune 12.9.1 MedImmune Company Details 12.9.2 Company Description and Business Overview 12.9.3 Prophylactic Human Vaccines Introduction 12.9.4 MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.9.5 MedImmune Recent Development 12.10 Merck 12.10.1 Merck Company Details 12.10.2 Company Description and Business Overview 12.10.3 Prophylactic Human Vaccines Introduction 12.10.4 Merck Revenue in Prophylactic Human Vaccines Business (2014-2019) 12.10.5 Merck Recent Development 12.11 Pfizer 12.12 Sanofi Pasteur 12.13 Serum Institute of India 12.14 Shanghai BravoBio 12.15 Seqirus 12.16 SK Chemicals 12.17 Takeda Pharmaceutical Company 12.18 Zydus Cadila 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Prophylactic Human Vaccines Key Market Segments Table Key Players Prophylactic Human Vaccines Covered Table Global Prophylactic Human Vaccines Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Prophylactic Human Vaccines Market Size Market Share by Type 2014-2025 Figure Type I Figures Table Key Players of Type I Figure Type II Figures Table Key Players of Type II Table Global Prophylactic Human Vaccines Market Size Growth by Application 2014-2025 (Million US$) Figure Pediatric Prophylactic Vaccines Case Studies Figure Adult Prophylactic Vaccines Case Studies Figure Prophylactic Human Vaccines Report Years Considered Table Global Prophylactic Human Vaccines Market Size 2014-2025 (Million US$) Figure Global Prophylactic Human Vaccines Market Size and Growth Rate 2014-2025 (Million US$) Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2025 (Million US$) Table Global Prophylactic Human Vaccines Market Size by Regions 2014-2019 (Million US$) Table Global Prophylactic Human Vaccines Market Share by Regions 2014-2019 Figure Global Prophylactic Human Vaccines Market Share by Regions 2014-2019 Figure Global Prophylactic Human Vaccines Market Share by Regions 2019 Table Market Top Trends Table Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019) (Million US$) Table Global Prophylactic Human Vaccines Market Share by Manufacturers (2014-2019) Figure Global Prophylactic Human Vaccines Market Share by Manufacturers in 2018 Table Global Prophylactic Human Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Prophylactic Human Vaccines Product/Solution/Service Table Date of Enter into Prophylactic Human Vaccines Market Table Mergers & Acquisitions, Expansion Plans Table Global Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table Global Prophylactic Human Vaccines Market Size Share by Type (2014-2019) Figure Global Prophylactic Human Vaccines Market Size Market Share by Type (2014-2019) Table Global Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table Global Prophylactic Human Vaccines Market Size Share by Application (2014-2019) Figure Global Prophylactic Human Vaccines Market Size Market Share by Application (2014-2019) Figure Global Prophylactic Human Vaccines Revenue Market Share by Application in 2018 Figure United States Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table United States Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table United States Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table United States Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table United States Prophylactic Human Vaccines Market Share by Type (2014-2019) Table United States Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table United States Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure Europe Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table Europe Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table Europe Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table Europe Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table Europe Prophylactic Human Vaccines Market Share by Type (2014-2019) Table Europe Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table Europe Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure China Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table China Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table China Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table China Prophylactic Human Vaccines Market Size by Type (2014-20189) (Million US$) Table China Prophylactic Human Vaccines Market Share by Type (2014-2019) Table China Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table China Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure Japan Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table Japan Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table Japan Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table Japan Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table Japan Prophylactic Human Vaccines Market Share by Type (2014-2019) Table Japan Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table Japan Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure Southeast Asia Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table Southeast Asia Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Prophylactic Human Vaccines Market Share by Type (2014-2019) Table Southeast Asia Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure India Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table India Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table India Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table India Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table India Prophylactic Human Vaccines Market Share by Type (2014-2019) Table India Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table India Prophylactic Human Vaccines Market Share by Application (2014-2019) Figure Central & South America Prophylactic Human Vaccines Market Size 2014-2019 (Million US$) Table Central & South America Key Players Prophylactic Human Vaccines Revenue (2018-2019) (Million US$) Table Central & South America Key Players Prophylactic Human Vaccines Market Share (2018-2019) Table Central & South America Prophylactic Human Vaccines Market Size by Type (2014-2019) (Million US$) Table Central & South America Prophylactic Human Vaccines Market Share by Type (2014-2019) Table Central & South America Prophylactic Human Vaccines Market Size by Application (2014-2019) (Million US$) Table Central & South America Prophylactic Human Vaccines Market Share by Application (2014-2019) Table ALK Company Details Table ALK Revenue in Prophylactic Human Vaccines Business (2014-2019) (Million US$) Figure ALK Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table ALK Recent Development Table Altimmune Company Details Table Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Altimmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Altimmune Recent Development Table Bavarian Nordic Company Details Table Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Bavarian Nordic Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Bavarian Nordic Recent Development Table BiondVax Pharmaceuticals Company Details Table BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure BiondVax Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table BiondVax Pharmaceuticals Recent Development Table Bharat Biotech International Company Details Table Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Bharat Biotech International Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Bharat Biotech International Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table GlaxoSmithKline Recent Development Table Hualan Biological Engineering Company Details Table Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Hualan Biological Engineering Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Hualan Biological Engineering Recent Development Table Janssen Pharmaceuticals Company Details Table Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Janssen Pharmaceuticals Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Janssen Pharmaceuticals Recent Development Table MedImmune Company Details Table MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure MedImmune Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table MedImmune Recent Development Table Merck Company Details Table Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Prophylactic Human Vaccines Business (2014-2019) Table Merck Recent Development Table Pfizer Company Details Table Sanofi Pasteur Company Details Table Serum Institute of India Company Details Table Shanghai BravoBio Company Details Table Seqirus Company Details Table SK Chemicals Company Details Table Takeda Pharmaceutical Company Company Details Table Zydus Cadila Company Details Table Global Prophylactic Human Vaccines Market Size by Regions (Million US$) 2019-2025 Figure Global Prophylactic Human Vaccines Market Size Share by Regions (2019-2025) Figure Global Prophylactic Human Vaccines Market Size Share by Regions in 2025 Figure United States Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure Europe Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure China Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure Japan Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure India Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Prophylactic Human Vaccines Market Size Forecast (2019-2025)(Million USD) Table Global Prophylactic Human Vaccines Market Size by Product (2019-2025) (Million US$) Figure Global Prophylactic Human Vaccines Market Size by Product (2019-2025) Figure Global Prophylactic Human Vaccines Market Size by Product in 2025 Table Global Prophylactic Human Vaccines Market Size by Application (2019-2025) (Million US$) Figure Global Prophylactic Human Vaccines Market Size by Application (2019-2025) Figure Global Prophylactic Human Vaccines Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

ALK Altimmune Bavarian Nordic BiondVax Pharmaceuticals Bharat Biotech International GlaxoSmithKline Hualan Biological Engineering Janssen Pharmaceuticals MedImmune Merck Pfizer Sanofi Pasteur Serum Institute of India Shanghai BravoBio Seqirus SK Chemicals Takeda Pharmaceutical Company Zydus Cadila